A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient

被引:12
作者
Liu, Yihui [1 ]
Xu, Jiang [2 ]
Tao, Wanyun [3 ]
Yu, Rong [4 ]
Zhang, Xinjiang [1 ,2 ]
机构
[1] Yangzhou Univ, Dept Neurol, Affiliated Hosp, Yangzhou 225000, Jiangsu, Peoples R China
[2] Yangzhou Univ, Med Sch, Yangzhou, Jiangsu, Peoples R China
[3] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[4] Cent S Univ, XiangYa Hosp 2, Dept Anesthesiol, Changsha, Hunan, Peoples R China
关键词
Hypertriglyceridemia; HTG; LMF1; Compound mutation; LIPOPROTEIN-LIPASE; ENDOPLASMIC-RETICULUM; TRIGLYCERIDE; DEFICIENCY; ENZYME; LETHAL; GENE;
D O I
10.5551/jat.44537
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C>T/p.P86L and c.1184C>T/p. T3951) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG.
引用
收藏
页码:136 / 144
页数:9
相关论文
共 50 条
  • [21] Identification of a novel and heterozygous LMF1 nonsense mutation in an acute pancreatitis patient with severe hypertriglyceridemia, severe obesity and heavy smoking
    Wei-Wei Chen
    Qi Yang
    Xiao-Yao Li
    Xiao-Lei Shi
    Na Pu
    Guo-Tao Lu
    Zhi-Hui Tong
    Jian-Min Chen
    Wei-Qin Li
    Lipids in Health and Disease, 18
  • [22] Novel compound heterozygous mutations of the FBP1 gene in a patient with hypoglycemia and lactic acidosis: A case report
    Xin, Bin
    Chen, Haiming
    Liu, Tianyi
    Wu, Yue
    Hu, Qingyang
    Dong, Xue
    Li, Zhong
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2024, 12 (01):
  • [23] The role of lipase maturation factor 1 in hypertriglyceridaemia and atherosclerosis: An update
    Dabravolski, Siarhei A.
    Churov, Alexey, V
    Sukhorukov, Vasily N.
    Kovyanova, Tatiana, I
    Beloyartsev, Dmitry F.
    Lyapina, Irina N.
    Orekhov, Alexander N.
    SAGE OPEN MEDICINE, 2024, 12
  • [24] Characterization of a Missense Mutation in the Catalytic Domain and a Splicing Mutation of Coagulation Factor X Compound Heterozygous in a Chinese Pedigree
    Feng, Yuanzheng
    Ma, Jiewen
    Tang, Liang, V
    Lin, Wenyi
    Tao, Yanyi
    Cheng, Zhipeng
    Hu, Yu
    GENES, 2021, 12 (10)
  • [25] Novel LMF1 Nonsense Mutation in a Patient with Severe Hypertriglyceridemia
    Cefalu, Angelo B.
    Noto, Davide
    Arpi, Maria Luisa
    Yin, Fen
    Spina, Rossella
    Hilden, Hannele
    Barbagallo, Carlo M.
    Carroccio, Antonio
    Tarugi, Patrizia
    Squatrito, Sebastiano
    Vigneri, Riccardo
    Taskinen, Marja-Riitta
    Peterfy, Miklos
    Averna, Maurizio R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (11) : 4584 - 4590
  • [26] Factor X heterozygous mutation in a patient with potential risk of bleeding A case report
    Arita, Kotaro
    Niimi, Hideki
    Yamagishi, Nana
    Ueno, Tomohiro
    Kitajima, Isao
    Sugiyama, Toshiro
    MEDICINE, 2018, 97 (23)
  • [27] A Chinese patient with recurrent pancreatitis during pregnancy induced by hypertriglyceridemia associated with compound heterozygosity (GLu242Lys and Leu252VaL) in the lipoprotein lipase gene
    Liu, Ying
    Lun, Yu
    Lv, Wenshan
    Hou, Xu
    Wang, Yangang
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (01) : 199 - 203
  • [28] Identification of a compound heterozygous inactivating ABCC8 gene mutation responsible for young-onset diabetes with exome sequencing
    Matsutani, Norihiko
    Furuta, Hiroto
    Matsuno, Shohei
    Oku, Yoshimasa
    Morita, Shuhei
    Uraki, Shinsuke
    Doi, Asako
    Furuta, Machi
    Iwakura, Hiroshi
    Ariyasu, Hiroyuki
    Nishi, Masahiro
    Akamizu, Takashi
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (02) : 333 - 336
  • [29] Novel compound heterozygous SPTA1 mutations in a patient with hereditary elliptocytosis
    Ma, Shiyue
    Qin, Jinqiu
    Wei, Aiqiu
    Li, Xiaohong
    Qin, Yuanyuan
    Liao, Lin
    Lin, Faquan
    MOLECULAR MEDICINE REPORTS, 2018, 17 (04) : 5903 - 5911
  • [30] Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report
    Zhang, Jian-hui
    Chen, Hui
    Ruan, Dan-dan
    Chen, Ying
    Zhang, Li
    Gao, Mei-zhu
    Chen, Qian
    Yu, Hong-ping
    Wu, Jia-yi
    Lin, Xin-fu
    Fang, Zhu-ting
    Zheng, Xiao-ling
    Luo, Jie-wei
    Liao, Li-sheng
    Li, Hong
    ANNALS OF HEMATOLOGY, 2024, 103 (05) : 1765 - 1774